Overview

Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder

Status:
Not yet recruiting

Trial end date:
2022-06-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder on buprenorphine or methadone treatment.

Phase:

Phase 2

Details

Lead Sponsor:

Brigham and Women's Hospital

Collaborators:

Harvard Medical School
Harvard Medical School (HMS and HSDM)

Treatments:

Cannabidiol
Epidiolex